Australian-New Zealand Clinical Trial: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of Inhaled SUN-001 in Healthy Volunteers

Australia, Oct. 22 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of Inhaled SUN-001 in Healthy Volunteers’. The following are the other relevant details related to the trial:

Trial ID: 389889

Submit Date: 7/23/25 14:45

Study Type: Interventional

Intervention: The study is a randomized, double-blind, placebo-controlled, single and multiple ascending dose study of inhaled SUN-001 in healthy adult volunteers. The study is comprised of two parts as follows: *Part A – three sequentially run, single ...